Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inhibition of Interleukin 10 Enhances Antitumor Immune Activity in Liver Metastases of Human Colorectal Cancer

  • August 1, 2026

Share

Objective:

To investigate the effects of interleukin 10 blockade on antitumor immune function in liver metastases of human colorectal cancer.

Approach:
  • Study Design: The study involved experimental conditions comparing CAR-T therapy with and without IL-10 blockade.
Key Findings:
  • Errors were identified in figure 5 and the Results section, specifically regarding the images used and the reported sample sizes for certain experimental conditions.
  • The sample size for control CAR-T and anti-IL-10 antibody was corrected from n=4 to n=2, affecting the interpretation of the results.
  • Statistical significance and p-values remained unchanged despite the corrections.
Interpretation:

The overall findings of the study remain consistent despite the corrections made to the data.

Limitations:
  • The initial errors in figure 5 and the Results section may affect the interpretation of the data, particularly in understanding the efficacy of the treatments.
  • Sample sizes were smaller than initially reported for some experimental conditions, which could limit the robustness of the findings.
Conclusion:

The authors confirmed that the corrections do not alter the overall findings of the study.

Sources:

Original Source(s)

Related Content